Logo image of OCUL

OCULAR THERAPEUTIX INC (OCUL) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:OCUL - US67576A1007 - Common Stock

11.425 USD
+0.18 (+1.56%)
Last: 12/3/2025, 10:20:06 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
OCUL revenue by date.OCUL revenue by date.
51.49M
18.31%
58.443M
13.50%
63.723M
9.03%
56.17M
-11.85%
66.139M
17.75%
101.28M
53.13%
225.44M
122.59%
590.14M
161.77%
1.072B
81.65%
1.566B
46.08%
2.022B
29.12%
EBITDA
YoY % growth
OCUL ebitda by date.OCUL ebitda by date.
-76.54M
-1.22%
-79.399M
-3.74%
-167.995M
-111.58%
-272.452M
-62.18%
1.639B
701.57%
-218.525M
-113.33%
-144.034M
34.09%
72.614M
150.41%
183.92M
153.28%
277.78M
51.03%
352.63M
26.95%
EBIT
YoY % growth
OCUL ebit by date.OCUL ebit by date.
-78.65M
-0.78%
-82.382M
-4.75%
-171.781M
-108.52%
-269.693M
-57.00%
-282.611M
-4.79%
-245.591M
13.10%
-244.394M
0.49%
36.871M
115.09%
444.14M
1,104.58%
840.33M
89.20%
1.204B
43.28%
Operating Margin
OCUL operating margin by date.OCUL operating margin by date.
-152.75%-140.96%-269.57%-480.14%-427.30%-242.49%-108.41%6.25%41.43%53.66%59.55%
EPS
YoY % growth
OCUL eps by date.OCUL eps by date.
-0.96
-966.67%
-1.17
-21.87%
-1.47
-25.64%
-1.49
-1.48%
-1.41
5.31%
-1.19
15.82%
-0.63
46.82%
0.32
150.00%
0.79
148.39%
1.17
49.35%
1.48
26.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.33
-12.60%
-0.35
8.05%
-0.36
8.95%
-0.37
1.84%
-0.39
-19.63%
-0.35
0.75%
-0.36
-0.53%
-0.22
39.84%
-0.11
71.28%
Revenue
Q2Q % growth
16.554M
-3.10%
14.503M
35.57%
15.421M
14.58%
15.8M
8.64%
16.796M
1.46%
15.55M
7.22%
17.177M
11.39%
32.268M
104.23%
49.404M
194.14%
EBITDA
Q2Q % growth
-73.797M
-57.72%
-72.359M
-14.97%
-73.766M
-12.39%
-75.205M
-14.60%
-71.655M
2.90%
-72.553M
-0.27%
-74.052M
-0.39%
-47.42M
36.95%
-24.511M
65.79%
EBIT
Q2Q % growth
-71.714M
-41.79%
-73.246M
-14.60%
-74.567M
-10.24%
-78.42M
-14.15%
-77.227M
-7.69%
-72.553M
0.95%
-74.052M
0.69%
-47.42M
39.53%
-24.511M
68.26%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.38
-72.73%
-0.37-0.01-1.62%
Q2 2025
Q2Q % growth
-0.39
-50.00%
-0.36-0.03-7.83%
Q1 2025
Q2Q % growth
-0.38
45.71%
-0.30-0.08-26.63%
Q4 2024
Q2Q % growth
-0.29
17.14%
-0.26-0.03-12.97%
Q3 2024
Q2Q % growth
-0.22
-29.41%
-0.250.0310.95%
Q2 2024
Q2Q % growth
-0.26 -0.23-0.03-15.12%
Q1 2024
Q2Q % growth
-0.70
-79.49%
-0.20-0.50-258.50%
Q4 2023
Q2Q % growth
-0.35
-45.83%
-0.31-0.04-12.87%
Q3 2023
Q2Q % growth
-0.17
45.16%
-0.290.1241.99%
Q2 2023
Q2Q % growth
-0.26
-4.00%
-0.310.0515.60%
Q1 2023
Q2Q % growth
-0.39
-143.75%
-0.27-0.12-45.11%
Q4 2022
Q2Q % growth
-0.24
-380.00%
-0.260.027.12%
Q3 2022
Q2Q % growth
-0.31
-1,133.33%
-0.24-0.07-27.70%
Q2 2022
Q2Q % growth
-0.25
-127.27%
-0.23-0.02-6.56%
Q1 2022
Q2Q % growth
-0.16
-500.00%
-0.270.1139.67%
Q4 2021
Q2Q % growth
-0.05
95.87%
-0.240.1979.14%
Q3 2021
Q2Q % growth
0.03
114.29%
-0.270.30111.10%
Q2 2021
Q2Q % growth
-0.11
82.81%
-0.220.1149.84%
Q1 2021
Q2Q % growth
0.04
109.76%
-0.210.25118.98%
Q4 2020
Q2Q % growth
-1.21
-128.30%
-0.17-1.04-611.75%
Q3 2020
Q2Q % growth
-0.21
47.50%
-0.250.0415.10%
Q2 2020
Q2Q % growth
-0.64
-12.28%
-0.32-0.32-102.40%
Q1 2020
Q2Q % growth
-0.41
14.58%
-0.38-0.03-8.64%
Q4 2019
Q2Q % growth
-0.53 -0.46-0.07-15.47%
Q3 2019
Q2Q % growth
-0.40 -0.480.0817.44%
Q2 2019
Q2Q % growth
-0.57 -0.49-0.08-17.03%
Q1 2019
Q2Q % growth
-0.48 -0.43-0.05-12.58%
OCUL Yearly EPS VS EstimatesOCUL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
14.544M
-5.71%
14.919M-375K-2.51%
Q2 2025
Q2Q % growth
13.459M
-18.14%
13.518M-59K-0.44%
Q1 2025
Q2Q % growth
10.698M
-27.59%
17.169M-6.471M-37.69%
Q4 2024
Q2Q % growth
17.083M
15.41%
17.549M-466K-2.66%
Q3 2024
Q2Q % growth
15.425M
2.28%
17.484M-2.059M-11.78%
Q2 2024
Q2Q % growth
16.441M
8.26%
16.14M301K1.86%
Q1 2024
Q2Q % growth
14.774M
10.47%
15.722M-948K-6.03%
Q4 2023
Q2Q % growth
14.802M
5.13%
16.021M-1.219M-7.61%
Q3 2023
Q2Q % growth
15.081M
25.99%
15.558M-477K-3.07%
Q2 2023
Q2Q % growth
15.186M
23.77%
14.943M243K1.63%
Q1 2023
Q2Q % growth
13.374M
1.39%
14.378M-1.004M-6.98%
Q4 2022
Q2Q % growth
14.08M
14.38%
13.804M276K2.00%
Q3 2022
Q2Q % growth
11.97M
-1.48%
14.556M-2.586M-17.77%
Q2 2022
Q2Q % growth
12.27M
4.69%
14.532M-2.262M-15.57%
Q1 2022
Q2Q % growth
13.19M
79.70%
14.48M-1.29M-8.91%
Q4 2021
Q2Q % growth
12.31M
67.48%
14.727M-2.417M-16.41%
Q3 2021
Q2Q % growth
12.15M
106.63%
12.703M-553K-4.35%
Q2 2021
Q2Q % growth
11.72M
646.50%
11.042M678K6.14%
Q1 2021
Q2Q % growth
7.34M
181.23%
7.789M-449K-5.76%
Q4 2020
Q2Q % growth
7.35M
225.22%
9.954M-2.604M-26.16%
Q3 2020
Q2Q % growth
5.88M
608.43%
5.601M279K4.98%
Q2 2020
Q2Q % growth
1.57M
141.54%
1.529M41K2.68%
Q1 2020
Q2Q % growth
2.61M
432.65%
2.897M-287K-9.91%
Q4 2019
Q2Q % growth
2.26M 2.596M-336K-12.94%
Q3 2019
Q2Q % growth
830K 591.6K238.4K40.30%
Q2 2019
Q2Q % growth
650K 752.352K-102.352K-13.60%
Q1 2019
Q2Q % growth
490K 436.56K53.44K12.24%
OCUL Yearly Revenue VS EstimatesOCUL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS6.16% 15.58% 0% 4.34%
Revenue-0.28% 0.02% 0% 0.37%